GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...

GSK stock opened at GBX 1,444.50 ($18.15) on Friday. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. GSK plc has a 52 week low of GBX 1,282.50 ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

GSK is prioritizing development of its hepatitis ... to discuss her company's fourth-quarter and full-year earnings, CEO Emma Walmsley said that when it came to the British pharma’s infectious ...

Chief executive Emma Walmsley said: “GSK delivered another year of excellent performance in 2024, with strong sales and core profit growth driven by accelerating momentum of our specialty medicines ...

Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. GSK's Beat-and-Raise ...

That's why many watch owners from the casual enthusiast to the dedicated collector turn to Stoll & Co. As a leader in the watchmaking service industry, the company has set a golden standard of ...

GSK's shares were up 6% at 1342 GMT after the British drugmaker's fourth-quarter results also topped expectations. Since taking the helm in 2017, CEO Emma Walmsley has returned GSK to growth with ...

GSK also has no or minimal exposure to any potential US trade tariffs on Mexico, China and Canada, Chief Executive Officer Emma Walmsley said on a call with reporters on Wednesday. Tariffs are ...